Indivior Pharmaceuticals (INDV) Cash & Equivalents (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted Cash & Equivalents of $222 million for Q2 2026, down 56.5% from $510 million a year earlier but up 26.9% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Indivior Pharmaceuticals' Cash & Equivalents came in at $195 million, down 38.9% from FY2024.
- Annual Cash & Equivalents shows a four-year compound annual growth rate of -35.1% (FY2021 to FY2025).
- In prior years, Indivior Pharmaceuticals' Cash & Equivalents was $319 million in FY2024 (+0.9%), $316 million in FY2023 (-59.2%), $774 million in FY2022 (-29.8%) and $1.1 billion in FY2021.
- Quarterly Cash & Equivalents has run from a low of $175 million in Q1 2026 to a high of $1.1 billion in Q4 2021 over five years.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last three quarters, with an average decline of 36.8% over the last four quarters.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $175 million (Q1 2026), $195 million (Q4 2025) and $445 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.18 Bn | 3.14 Bn | 294.00 Mn | 222.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 222.00 Mn |
| Mar 31, 2026 | 175.00 Mn |
| Dec 31, 2025 | 195.00 Mn |
| Sep 30, 2025 | 445.00 Mn |
| Jun 30, 2025 | 510.00 Mn |
| Mar 31, 2025 | 372.00 Mn |
| Dec 31, 2024 | 319.00 Mn |
| Dec 31, 2023 | 316.00 Mn |
| Dec 31, 2022 | 774.00 Mn |
| Dec 31, 2021 | 1.10 Bn |
API Access
Indivior Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();